Observed Antimicrobial Resistance in Streptococcus pneumoniae Isolates in Children (January 2011–February 2020)
| Antibiotic . | Invasive PD (n = 964) . | Noninvasive PD (n = 6641) . | Total (N = 7605) . |
|---|---|---|---|
| Resistance to ≥1 drug class | 407 (42.2) | 3915 (59.0) | 4322 (56.8) |
| Resistance to ≥2 drug classes | 143 (14.8) | 2193 (33.0) | 2336 (30.7) |
| Resistance by antibiotic class | |||
| Macrolide | 306 (31.7) | 2731 (41.1) | 3037 (39.9) |
| Penicillin | 199 (20.6) | 2813 (42.4) | 3012 (39.6) |
| Tetracycline | 72 (7.5) | 761 (11.5) | 833 (11.0) |
| ESC | 34 (3.5) | 483 (7.3) | 517 (6.8) |
| Fluoroquinolone | 4 (0.4) | 29 (0.4) | 33 (0.4) |
| Antibiotic . | Invasive PD (n = 964) . | Noninvasive PD (n = 6641) . | Total (N = 7605) . |
|---|---|---|---|
| Resistance to ≥1 drug class | 407 (42.2) | 3915 (59.0) | 4322 (56.8) |
| Resistance to ≥2 drug classes | 143 (14.8) | 2193 (33.0) | 2336 (30.7) |
| Resistance by antibiotic class | |||
| Macrolide | 306 (31.7) | 2731 (41.1) | 3037 (39.9) |
| Penicillin | 199 (20.6) | 2813 (42.4) | 3012 (39.6) |
| Tetracycline | 72 (7.5) | 761 (11.5) | 833 (11.0) |
| ESC | 34 (3.5) | 483 (7.3) | 517 (6.8) |
| Fluoroquinolone | 4 (0.4) | 29 (0.4) | 33 (0.4) |
Data are presented as No. (%). Totals may not equal 100% due to rounding.
Abbreviations: ESC, extended-spectrum cephalosporins; PD, pneumococcal disease.
Observed Antimicrobial Resistance in Streptococcus pneumoniae Isolates in Children (January 2011–February 2020)
| Antibiotic . | Invasive PD (n = 964) . | Noninvasive PD (n = 6641) . | Total (N = 7605) . |
|---|---|---|---|
| Resistance to ≥1 drug class | 407 (42.2) | 3915 (59.0) | 4322 (56.8) |
| Resistance to ≥2 drug classes | 143 (14.8) | 2193 (33.0) | 2336 (30.7) |
| Resistance by antibiotic class | |||
| Macrolide | 306 (31.7) | 2731 (41.1) | 3037 (39.9) |
| Penicillin | 199 (20.6) | 2813 (42.4) | 3012 (39.6) |
| Tetracycline | 72 (7.5) | 761 (11.5) | 833 (11.0) |
| ESC | 34 (3.5) | 483 (7.3) | 517 (6.8) |
| Fluoroquinolone | 4 (0.4) | 29 (0.4) | 33 (0.4) |
| Antibiotic . | Invasive PD (n = 964) . | Noninvasive PD (n = 6641) . | Total (N = 7605) . |
|---|---|---|---|
| Resistance to ≥1 drug class | 407 (42.2) | 3915 (59.0) | 4322 (56.8) |
| Resistance to ≥2 drug classes | 143 (14.8) | 2193 (33.0) | 2336 (30.7) |
| Resistance by antibiotic class | |||
| Macrolide | 306 (31.7) | 2731 (41.1) | 3037 (39.9) |
| Penicillin | 199 (20.6) | 2813 (42.4) | 3012 (39.6) |
| Tetracycline | 72 (7.5) | 761 (11.5) | 833 (11.0) |
| ESC | 34 (3.5) | 483 (7.3) | 517 (6.8) |
| Fluoroquinolone | 4 (0.4) | 29 (0.4) | 33 (0.4) |
Data are presented as No. (%). Totals may not equal 100% due to rounding.
Abbreviations: ESC, extended-spectrum cephalosporins; PD, pneumococcal disease.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
